Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation

View ORCID ProfileChad R. Wells, View ORCID ProfileAbhishek Pandey, View ORCID ProfileSeyed M. Moghadas, Burton H. Singer, Gary Krieger, Richard J.L. Heron, David E. Turner, Justin P. Abshire, Kimberly M. Phillips, A. Michael Donoghue, Alison P. Galvani, View ORCID ProfileJeffrey P. Townsend
doi: https://doi.org/10.1101/2021.08.23.21262499
Chad R. Wells
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chad R. Wells
Abhishek Pandey
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abhishek Pandey
Seyed M. Moghadas
2Agent-Based Modelling Laboratory, York University, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seyed M. Moghadas
Burton H. Singer
3Emerging Pathogens Institute, University of Florida, P.O. Box 100009, Gainesville, FL 32610, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Krieger
4NewFields E&E, Boulder, Colorado 80301, USA
5Skaggs School of Pharmacy and Pharmaceutical Science, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J.L. Heron
6BP Plc, 1 ST James’s Square, London, England SW1Y 4PD, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Turner
7BP America Inc, 501 Westlake Park Boulevard, Houston, Texas 77079, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin P. Abshire
8HSE Specialties, BHP Petroleum, 1500 Post Oak Blvd, Houston, Texas 77056, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly M. Phillips
9BHP Petroleum, 1500 Post Oak Blvd, Houston, Texas 77056, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Michael Donoghue
10Group HSE, BHP Group Ltd, 171 Collins Street, Melbourne, Victoria 3000, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison P. Galvani
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, Connecticut, 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey P. Townsend
11Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut 06525, USA
12Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut 06510, USA
13Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06511, USA
14Program in Microbiology, Yale University, New Haven, Connecticut 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey P. Townsend
  • For correspondence: Jeffrey.Townsend@yale.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Rapid antigen (RA) tests are being increasingly employed to detect COVID-19 infections in quarantine and surveillance. We conducted a comparative analysis of quarantine durations, testing frequencies, and false-positive rates for all of the 18 RA tests with emergency use authorization (EUA) from the FDA, and an RT-PCR test. For each test, we employed a mathematical model of imminent infections to calculate the effective reproductive number in the context of the test used for quarantine or serial testing. We informed the model with data on test specificity, temporal diagnostic sensitivity, and COVID-19 infectiousness. Our results demonstrate that the relative effectiveness of RA and RT-PCR tests in reducing post-quarantine transmission depends on the quarantine duration and the turnaround time of testing results. For quarantines shorter than five days, RA test on entry to and on exit from quarantine reduced onward transmission more than a single RT-PCR test conducted upon exit. Conducting surveillance via serial RT-PCR testing with a 24-h turnaround time, the minimum testing frequency paired with isolation of positives that is required to suppress the effective reproduction number (RE) below one was found to be every six days. RA tests reduce RE below one when conducted at a minimum frequency that ranges from every six days to every eight days. Our analysis also highlights that the risk of onward transmission during serial testing increases with the delay in obtaining the results. These RA test-specific results are an important component of the tool set for policy decision-making, and demonstrate that judicious selection of an appropriate RA test can supply a viable alternative to RT-PCR in efforts to control the spread of disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was supported by the Notsew Orm Sands Foundation BHP and BP. SMM acknowledges the support from the Canadian Institutes of Health Research [OV4-170643, COVID-19 Rapid Research] and the Natural Sciences and Engineering Research Council of Canada, Emerging Infectious Disease Modelling, MfPH grant.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The use of the onshore and offshore testing data of the oil platform employees was approved by the Human Participants Review Sub-Committee, York University's Ethics Review Board (Certificate Number: 2021-003).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Acknowledgement section has been updated

Data Availability

All data is referenced and provided within the main text or supplementary material.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation
Chad R. Wells, Abhishek Pandey, Seyed M. Moghadas, Burton H. Singer, Gary Krieger, Richard J.L. Heron, David E. Turner, Justin P. Abshire, Kimberly M. Phillips, A. Michael Donoghue, Alison P. Galvani, Jeffrey P. Townsend
medRxiv 2021.08.23.21262499; doi: https://doi.org/10.1101/2021.08.23.21262499
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative analyses of all FDA EUA-approved rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation
Chad R. Wells, Abhishek Pandey, Seyed M. Moghadas, Burton H. Singer, Gary Krieger, Richard J.L. Heron, David E. Turner, Justin P. Abshire, Kimberly M. Phillips, A. Michael Donoghue, Alison P. Galvani, Jeffrey P. Townsend
medRxiv 2021.08.23.21262499; doi: https://doi.org/10.1101/2021.08.23.21262499

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1748)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2783)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (555)
  • Occupational and Environmental Health (597)
  • Oncology (1457)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)